Moderna’s coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities

Moderna just finished recruiting 30,000 people for its coronavirus vaccine trial. One graph reveals how the biotech slowed down its research to recruit more minorities.

Minorities make up 37% of the study, but that percentage was on track to be much lower until the company slowed enrollment and..